Genelux Corporation

NASDAQ:GNLX

Biotechnology

Healthcare
$2.00 +2.63%

+$0.08 today

Market cap
$90.49M
Beta
0.55
P/E (TTM)
-3.0
EPS (TTM)
-$0.98
52W Low $2.29High $8.54

Volume 0.25M

Average 0.19M

Private 5-step workspace

Build a GNLX investment thesis

Turn Genelux Corporation research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.